Peptide Based Gastrointestinal Disorders Therapeutics Sales to reach a valuation in excess of US$ 600 Mn by 2022
Drug makers are increasingly partnering with medical research centers and institutes to develop more effective peptide drugs. This, in turn, is projected to make a [read full press release…]
